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Abstract  
Context: Sub-Saharan Africa faces an increasing incidence and prevalence of life-
limiting and life-threatening conditions. These conditions are associated with a 
significant burden of pain linked to high morbidity and disability that is poorly assessed 
and undertreated. Barriers to effective pain management partly relate to lack of access 
to opioid analgesia and challenges in their administration.   
 
Objectives: To identify country-specific and broader regional barriers to access, as well 
as the administration of opioids, and generate recommendations for advancing pain 
management in Southern Africa.  
 
Methods: A parallel mixed methods design was used across three countries: 
Mozambique, Swaziland and Zimbabwe.  Three activities were undertaken: (i) a review 
of regulatory and policy documentation; (ii) group interviews, and; (iii) a self-
administered key informant survey.  
 
Results: Barriers to accessing opioid analgesics for medical use include: overly 
restrictive controlled medicines’ laws; use of stigmatizing language in key documents; 
inaccurate actual opioid consumption estimation practices; knowledge gaps in the 
distribution, storage and prescription of opioids; critical shortage of prescribers, and; 
high out-of-pocket financial expenditures for patients against a backdrop of high levels 
of poverty. 
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Conclusion: Policies and relevant laws should be updated to ensure the legislative 
environment supports opioid access for pain management. Action plans for improving 
pain treatment for patients suffering from HIV or non-communicable diseases should 
address barriers at the different levels of the supply chain that involve policymakers, 
administrators and service providers.   
 
Keywords  
Opioids, analgesia, pain, supply chain, Africa, palliative care   
 
Running title: Opioid analgesia in three Southern Africa countries 
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Introduction  
Pain and symptom control are necessary for quality palliative care delivery in sub-
Saharan Africa (SSA)[12].  Pain is the commonest symptom experienced by those with 
the two most prevalent life-limiting and life-threatening conditions managed by palliative 
care services in the region: HIV and cancer[28,34]. For HIV, pain prevalence has been 
reported in 54 - 83% of patients [13,33], typically associated with sensory neuropathy, a 
common manifestation among HIV patients on antiretroviral therapy (ART)[36,38]. For 
cancer, pain prevalence is reported between 39 – 66%, dependent on disease stage 
[50]. The global burden of HIV and cancer (specifically infection-related) both 
disproportionately affect SSA [32,43]. Of the 36.7 million people globally living with 
HIV[48], 70% live in SSA[47]. The prevalence of cancers are rising, too[56], with an 
expectation that non-communicable diseases (NCDs) will be the lead cause of mortality 
in developing countries by 2030[37,52]. 
 
Palliative care improves pain management (e.g., through the provision of pain 
medication) for patients and their families [8,14,16] and patient survival[2,41]. However, 
for palliative care and pain treatment strategies to be effective, they must be 
incorporated by governments into all levels of their health care systems[6]. Effective 
pain management is subject to the availability of appropriate medicines, policies, 
educational frameworks and evidence[40]. For example, the World Health Organization 
(WHO) recommends morphine as the primary analgesic for the treatment of moderate-
to-severe pain [9,57,58]. Consumption of morphine in SSA is low, with large proportions 
of SSA patients enduring untreated pain[31]. Recently the International Narcotics 
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Control Board (INCB) and WHO have encouraged governments to evaluate their 
healthcare systems, laws and regulations, and identify and remove impediments to the 
availability of controlled substances for medical needs[20]. Global policy and legal 
frameworks exist to remove avoidable suffering among patients with advanced disease, 
and promote cheap and effective palliative care as a public health and human right 
issue [11,26]. However, reports of barriers to the supply and provision of opioids are 
widespread, highlighting inherent challenges faced in many countries within Africa: 
over-regulation[4], insufficiently trained clinical personnel to prescribe, cost[31], 
unreliable supply mechanisms and procurement difficulties[15], and weak health 
systems[7,31,35]. Countries continue to struggle to strike a balance between effective 
drug control and facilitating its availability for pain management in clinical practice.  
 
Studies on supply chains in palliative care services have occurred in some SSA regions 
[24,28], with significant investigation of the factors associated with lack of access 
[15,28,51].  To date, there has been no systematic assessment of factors affecting the 
supply and availability of opioids in Southern African countries. This is essential to 
address shortfalls in opioid supply and clinical use in a region with the highest HIV 
prevalence in SSA[48] and where unrelieved cancer pain is a significant problem[3]. 
This study aimed to identify country-level and regional specific factors relevant to the 
supply and availability of opioid analgesics for medical use in three countries in the 
region.  
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Methods  
Study setting and design 
A convergent parallel mixed methods design was used[5].  Three activities were 
undertaken: (i) a desktop review of regulatory and policy documentation; (ii) group 
interviews, and; (iii) a self-administered questionnaire among purposefully sampled key 
personnel involved in opioid regulation and clinical service providers. The self-
administered questionnaire sought information from respondents on their knowledge of, 
and attitudes to, supply chain issues and estimation practices concerning the availability 
of opioid analgesics. All data collection tools were pre-tested in Uganda and modified 
accordingly to ensure clarity of question items. This involved reviewing the tools for 
appropriateness for purpose based on the objectives, clarity and duration of interviews.  
 
The study covered three countries in Southern Africa: Mozambique, Swaziland and 
Zimbabwe (characteristics of these countries are outlined in Table 1). We purposively 
sampled countries at different levels of palliative care development using the Worldwide 
Palliative Care Alliance Palliative Care Development map[25]. Mozambique is at Level 
3a (isolated palliative care provision); Swaziland is at Level 3b (generalized palliative 
care provision); and Zimbabwe is at Level 4a (hospice-palliative care services are at a 
stage of preliminary integration into mainstream service provision). This approach 
enabled the identification of gaps and practices at the three levels of palliative care 
development in the region. Furthermore, it provides a more representative perspective 
of service provision in the region. 
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[Insert Table 1 about here] 
 
(i) Desktop documentation review 
To identify policy-level barriers to opioid access and availability, a desktop review of 
national regulatory and policy documents relevant to governing the use of controlled 
medicines – and specifically opioids – was conducted.  
 
(ii) Group interviews  
To understand existing supply chain mechanisms, three group interviews were 
conducted with key informants knowledgeable about the subject matter in each of the 
three countries. These discussions were directed by a topic guide informed by the 
document review and the content of INCB guidelines for the country assessment of 
national drug control policies[20]. The group interviews sought to explore the following 
policy- and legislative-level concern: government practices in regard to controlled 
medicines policies, legislation and regulation. Key issues addressed included: policy-
related barriers to access, planning for the availability and accessibility of controlled 
medicines, estimation procedures, other barriers to accessing opioids for pain 
management, practices around opioid prescription and dispensing and human resource 
concerns.   
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(iii) Key informant survey  
A questionnaire with closed-ended questions was developed to assess knowledge and 
attitudes related to opioid consumption, estimation, manufacturing, importation, 
distribution, storage, prescription and regulation. Participants provided socio-
demographic information and rated their agreement/disagreement with a series of 
statements in each of the domains using a 5-point Likert scale (i.e., strongly disagree, 
disagree, uncertain, agree, and strongly agree). Statements were also informed by the 
INCB guidelines[20]. The assessment of knowledge, attitudes and practices covered 
three core domains: (i) awareness of governments’ responsibility to integrate opioids in 
relevant national pharmaceutical and disease-specific policies; (ii) knowledge of 
regulating the distribution, storage and prescription of opioids, and; (iii) attitudes of 
participants regarding opioid consumption estimates, importation, storage, distribution 
and prescription. Statements outlined INCB recommended practices on reporting 
frequency, management of controlled medicine stock, the role of strong opioids in the 
treatment of pain among patients, and attitudes toward opioid consumption estimation, 
importation and the manufacturing process.  
 
Sampling and data collection  
(i) Desktop documentation review 
To identify the scope of documents, we followed existing approaches to identifying 
health policy and systems relevant documents regarding governing use of controlled 
medicines[30]. We also reviewed INCB reports and guidelines to identify relevant 
documents to target.  We sought to identify reports, strategies, rapid response 
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summaries, policy dialogue reports, policies, plans, guidelines and evidence briefs for 
policy. The list of documents to be reviewed was shared with in country key informants 
to confirm their comprehensiveness and relevance. These were subsequently reviewed 
for content to identify barriers and good practices.   Documents written in Portuguese 
were reviewed by the Portuguese speaking policy experts in Mozambique. (LMN and 
LD) 
 
(ii) Group interviews   
Contact persons from national palliative care associations (Mozambique and 
Zimbabwe) and national Ministries of Health (Swaziland) identifyed and contacted group 
interview participants. Purposive sampling was used to select officials knowledgeable 
about the supply chain mechanisms at the different levels of service delivery.. These 
included representatives from: (i) the country inistry of Health; (ii) the pharmaceutical 
department in the medicines regulatory authority; (iii) the Ministry of Internal Affairs, and 
departments of law enforcement on controlled medicines; (iv) the Central Medical 
Stores, and; (v) health service delivery facilities. The interviews were conducted by two 
people (moderator and note taker). Field notes were taken during the interviews catchy 
quotes were captured verbatim and these were subsequently expanded into transcripts 
at the end of each day.   
 
(iii) Key informant survey 
Sampling for the key informants was undertaken at two levels: (i) purposive sampling of 
informants from the Medicines Regulatory Authority, with the aim of identifying those 
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knowledgeable about the subject matter and ensuring representation of the different 
levels of service delivery; (ii) snowball sampling (i.e., existing study subjects recruited 
future subjects from among their acquaintances) to identify service providers, using the 
group interview participants as the index points of contact. Officials who participated in 
the group interviews were requested to identify service providers within or affiliated to 
their respective departments to take part in the key informant survey. The service 
providers were drawn from both public and private facilities, national palliative care 
associations or palliative care help desks and other related programmes. The 
questionnaire was distributed to the respective personnel responsible for service 
provision for self-completion.  
 
Ethical approval to undertake the study was received from the Comité National de 
Bioética para a Saúde (CNBS) / Mozambique National Committee for Bioethics 
(reference number 26/CNBS/13, 2014), the Scientific and Ethics Committee of the 
Ministry of Health in Swaziland (reference number MH/599C/FWA 000 15267, August 
2013), and the Medical Research Council of Zimbabwe (reference number 
MRCZ/A/1800, August 2014). Written informed consent to participate in the study was 
obtained from all participants.  
 
Data analysis  
For the document review, we used the WHO Policy Guidelines for Controlled 
Substances[55]  to develop a template for assessing barriers and good practices in 
existing policy guidelines. The guidelines outline how to ensure balance in national 
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policies on controlled substances. All documents were appraised against this template. 
Good practices and barriers were documented in a summary table followed by content 
analysis of the data extracted.  
Data from group interviews were also analyzed using content analysis. Two data 
analysts (EN and EM) deconstructed the data manually and categorised and 
synthesised emergent themes. Texts were broken into segments representing salient 
concepts and labelled with a code[27,45]. Any discrepancies in the coding were 
resolved through discussion alongside any subsequent adjustments to coding. Cross-
cutting themes were identified and subsequently discussed by the research and in-
country teams.  SPSS version 16 was used to analyze the quantitative data from the 
self-administered questionnaires. A descriptive approach was taken, with data 
summarized by frequencies and proportions.  
 
Results   
(i) Desktop documentation review 
Documents identified and reviewed included controlled medicines policy documents (n = 
4) and regulatory frameworks (n = 11) (see Table 2).  
 
[Insert Table 2 about here] 
 
Identified potential barriers to opioid access included stigmatizing language, lack of 
balance when negotiating avoidance of illicit opioid use and access for medical use, and 
overly restrictive prescription practices:  
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• It was common for legal documents to contain stigmatising terms such as 
“dangerous drugs”, “dangerous substance”, for example in the Dangerous Drugs 
Act (Chapter 15:02) of Zimbabwe 
• Overly restrictive practices in prescribing were also noted in the policy document 
contents, with doctors as the main legal prescribers.  For example, in the 
National Palliative Care Trainees Manual (2013) for Swaziland, it is stated on 
page 81 that “Legislation on morphine use: Morphine is a controlled … class C 
drug in Swaziland. Prescribed by authorized clinicians – doctors”  
• National guidance favors availability of controlled medicines at higher levels of 
service delivery, such as hospitals, while not being available at primary health 
care level  
• Documents often do not accommodate the concept of balance, encouraging 
access to opioid analgesics for medical and scientific use while ensuring that 
diversion or illicit use of opioids is minimized. For example, Mozambique’s 
Criminal Jurisdiction Legal Framework Applicable to Trafficking and Consumption 
Narcotic Drugs, Psychotropic Substances, Precursors and other Substances 
Similar Effects Law No 3/97, dated 13 September 1997. Objectives of this law 
focus on the control of illicit use of controlled substances and in the Act there is 
no mention of the need for the use of controlled substances for scientific and 
medical purposes to control moderate to severe pain. 
• Mozambique is yet to achieve the milestone of embedding morphine in the 
national essential medicines list (i.e. medically necessary medicines that should 
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be provided in sufficient quantities, as unavailability would cause serious harm). 
Swaziland and Zimbabwe already have essential medicines lists[10,59], which 
include morphine as an essential medicine, that should be made available to all 
those in need.  
 
While potential barriers were identified, cross-cutting themes reflecting best practices 
also emerged. All three countries have designated authorities responsible for 
overseeing the importation, production, sale and distribution of controlled medicines. 
They also all have some form of policy guidelines to guide the delivery of palliative care 
services and regulate access to opioids for pain management.  
 
(ii) Estimation procedures and supply chain mechanisms  
In total, 33 participants (including government policy, licensing, supply chain and law 
enforcement personnel, National AIDS Program / palliative care associations and 
national palliative care coordination desks) participated in group interviews.  
 
[Insert Table 3 about here] 
 
These thematic issues are presented in Table 4 by country and explained below.                      
 
[Insert 4 about here] 
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Estimation procedures used for determining the need for opioids was consumption 
based across all three countries. This involves using previous consumption data to 
predict future need, which consequently guides the amounts imported for medical use. 
The burden of disease and total population are not used in these calculations:  
 
“In estimating for opioids need in Zimbabwe, past consumption is the main factor we 
consider. The burden of disease or total population is never included, so we cannot 
prevent shortages before the year ends. For example, in 2012, the case estimated 
amount was not sufficient, so a supplementary estimate was sent to INCB.” Group 
Interview ID 04, Zimbabwe 
 
Countries tried to include a 10% surplus in these estimates to prevent shortages before 
the year ends. In situations where the estimated amount was insufficient, 
supplementary estimates were sent to the INCB. All countries reported frequent stock-
outs (ranging from 50% of the time in Zimbabwe, to 80% in Mozambique). None of the 
countries mentioned using the integrated approach of combining consumption with 
morbidity data as recommended by the INCB[21].  
 
Stock outs of opioids were common and attributed to delays in the tendering process 
and scarcity of resources, particularly US dollars, required for the importation and 
distribution of opioids: 
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“Stock outs are very common here and this is due to several things. There are delays in 
the tendering process; also scarcity of resources is a problem, particularly dollars, 
required for the importation and distribution of opioids.” Group Interview ID 02, 
Mozambique 
 
Delays in mandatory reporting to the INCB were also mentioned in Swaziland as a 
challenge at the time of data collection: 
 
“The government has not submitted to the INCB the required quarterly and annual 
statistical reports because of the lack a technical person to take on this role for the last 
five years; this technical officer had just been recruited and hired in 2014.” Group 
Interview ID 10, Swaziland  
 
Several barriers to accessing opioids were also identified; these include the impact of 
distance to the nearest health facility and service availability, restrictive prescription 
privileges (only allowing morphine to be supplied on prescription at hospital sites), and 
rural-urban imbalances to pain management services (limited health worker numbers 
and stock in rural facilities). The rural-urban imbalances in access were exacerbated by 
the restrictive prescription practices which favour doctors who are mostly urban based:  
 
“The inadequacy of health worker numbers and the fact that morphine is only available 
in hospitals, where there were doctors to prescribe it, is also a limiting factor. Lack of 
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access is worse in rural areas which have fewer hospitals and fewer doctors”. Group 
Interview,ID 09 Mozambique  
  
“Pharmacies are mostly located in towns and liquid morphine is not easily accessed by 
users in rural areas. Prescription is restricted to registered doctors, most of whom are 
urban based so rural-urban imbalance in access is a problem”. Group Interview, 011 
Swaziland.   
 
User fees at the point of service delivery were in operation in the three countries and 
cited as a potential barrier to those who may not be able to afford these costs:  
 
“In Mozambique, there is a user fee of 5 metical [equivalent to about 17 US cents] at the 
point of access, there is a waiver for the very poor and those with chronic diseases but it 
is still a barrier.” Group Interview ID 01, Mozambique  
 
“There is a user fee of 10 emalangeni (equivalent to about US$1) at the point of access, 
after which all services and medicines could be accessed. It is a problem to some 
patients.”  Group Interview ID 05, Swaziland  
 
“Although Zimbabwe has a user fee policy, treatment for HIV and AIDS was supposed 
to be free; in reality; there is high out-of-pocket expenditure because essential 
medicines were not always available in public health facilities and patients have to buy 
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them from the open market. This increases costs for all health services, including 
palliative care and access to opioid analgesics.” Group Interview ID 06, Zimbabwe  
 
Group interview participants also highlighted several policy-level issues within existing 
policy documents that needed review to improve access to opioids for pain 
management. 
  
“Regarding regulation and legislation of the pharmaceutical industry in Swaziland, the 
current National Pharmaceutical Policy (2011c) states on page 11 that “The Pharmacy 
Act of 1929” … is outdated, does not provide for licensing … and regulatory functions … 
licensing of premises and registration of medicines is not done.” Group Interview ID 06, 
Swaziland  
 
“We have the Dangerous Drugs Act (Chapter 15:02) it should be revised to 
accommodate the concept of ‘balance’ and not focus only on the prevention of the illicit 
use of opioids. In this way, it will create an environment for supporting availability and 
access for the rational medical and scientific use of opioids”. Group Interview ID 09, 
Zimbabwe  
 
(iii) Key informant survey 
Characteristics of key informants  
In total, 88 participants from Mozambique (n = 26), Swaziland (n = 30) and Zimbabwe (n 
= 32) completed the key informant survey (see Table 5). Nearly two-thirds of 
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respondents were female, with 51.1% nurses and 20.4% non-medical professionals. 
Just over half (51.1%) identified themselves as a ‘service provider’.  
 
[Insert Table 5 about here] 
 
Knowledge, attitudes and practices regarding opioid analgesic supply, 
distribution and storage 
The level of awareness of governments’ responsibility to integrate opioids in relevant 
national pharmaceutical and disease-specific policies was generally good (i.e. scores 
are above 70% for knowledge about: the role of government in opioid regulation-need to 
have policy guidance on opioid regulation, need for moderate/severe pain management 
beyond cancer and supply chain requirements for controlled medicines). The role of 
government was deemed critical to improving opioid availability by ensuring controlled 
medicines are stocked like other medicines. Respondents were generally aware that 
HIV/AIDS may be associated with pain. The proportion of respondents who 
agreed/strongly agreed that physicians, nurses and other health professionals who are 
trained and qualified, at all levels of health care should be allowed to prescribe ranged 
between 33%-64%. Notably, the majority of respondents were more inclined towards 
very stringent measures regarding storage and prescription. Regarding estimation, 
importation and distribution, there was very low knowledge among respondents (see 
Table 6). The knowledge and attitudes on other domains highlighted areas that may 
require strengthening (i.e. less than 70% of respondents or more chose the correct 
option). 
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[Insert Table 6 about here] 
 
Respondents generally had accurate knowledge regarding collaboration of their 
countries with the INCB (range for agree/strongly agree scores 67%-100%). However, 
awareness of the respondents’ countries being signatories to international drug control 
conventions was generally low across the three countries (range 53%-61%). 
 
Integration and synthesis of findings and proposal for future initiatives  
Drawing on the synthesis of findings from the mixed methods study, we propose 
context-specific approaches to improve the supply and subsequent clinical use of 
opioids in Southern Africa in response to issues identified in this study. Proposed 
approaches are outlined in Figure 1, describing issues and approaches for each level of 
the opioid supply chain.   
 
[Insert Figure 1] 
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Discussion   
 
This study presents evidence on the processes and systems surrounding opioid 
availability in three Southern African countries. We propose context-specific solutions in 
response to issues identified that could be useful in improving access to opioids for pain 
management in the Southern Africa region. Findings from this review of policy and 
regulatory documentation revealed countries trying to institute appropriate policies and 
guidelines. While these have been developed across all three countries between 2011 
and 2014, barriers remain, including the use of stigmatizing language which may 
contribute to the fear of using opioid medicines and be associated with restrictive 
access [51].  Controlled medicine laws should not aim at diminishing access to opioid 
medicines for medical use but rather strengthen it. To strike a balance, the laws/policies 
should support optimization of safety whilst minimizing risk, avoiding negative 
consequences that could result from diversion or unintentional overdose. A lack of 
balance could ultimately have an impact on access to opioids for medical use both at 
the supply and prescription levels.  
 
Current opioid estimation practices do not mirror recommended best practices, which 
involve use of both consumption and disease incidence data[20,21].  Failure to follow 
these practices results in a significant gap between the number of deaths and those 
where analgesic treatment was available.  This may partly explain the high percentage 
of unmet pain treatment needs reported in Mozambique, Swaziland and Zimbabwe[44]. 
Furthermore, the escalating incidence of cancer and other NCDs could contribute to a 
widening of the gap between the amount of medication available for pain relief and the 
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amount needed[19,55]. The need to revise estimation procedures should be a high 
priority.   
 
There were cases where countries had not submitted INCB reports for some time. This 
finding echoes increasing reports of countries not submitting estimates for their 
controlled substances based upon careful assessment of population needs to the INCB, 
as required by the UN drug conventions[18]. This could explain why opioid consumption 
levels for pain treatment have increased in other parts of the world except in Asia, Africa 
and Middle Eastern countries[20]. The INCB has repeatedly reminded countries of their 
obligation to submit estimates based upon population need and has encouraged all 
countries to review their methods for preparing estimates to ensure they reflect the need 
for controlled medications[21].  The staff in charge of estimation and reporting in INCB 
procedures should be trained and mechanisms instituted to provide the data required 
for making estimations that incorporate disease burden.  In 2016, the INCB launched 
the Learning project, to provide technical assistance to member states to improve 
compliance with international drug control convention provisions. Through this initiative 
a series of three-day regional training seminars have been held for national authorities 
responsible for the implementation of the international drug control conventions, which 
included training on estimates. These were held in 2016 and 2017 in East Africa, South 
and East Asia, and Europe[49]. We recommend that the INCB considers holding a 
Southern Africa regional training seminar.  
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At the supply level, cost also affects the availability of opioids. Frequent stock-outs of 
opioids was highlighted as a common challenge and their causes were partly related to 
lack of financial resources to import opioid analgesics.  Mozambique is a low-income 
country with a per capita income of US$ 600, while in Zimbabwe 72% of the population 
live below the poverty line[42].  Amidst a chronic lack of financial resources, countries 
are encouraged to create capacity for the local production of basic oral morphine, in 
tablet or liquid form, at low cost[17]. While the sustainability of such services requires 
consideration, a number of countries have successfully initiated this approach[26]. At 
the patient level, some countries charge user fees as a strategy for leveraging 
resources to sustain the services, particularly in situations where government funding is 
deemed inadequate. Under the right to health, governments do not have to offer 
medications, such as oral morphine, free of charge. However, they must strive to ensure 
they are affordable to all[18].  
 
Restrictive prescription privileges continue to be a barrier to opioid medicine access, 
with prescribing mainly restricted to doctors in Mozambique and Swaziland. This finding 
further contributes to the converging evidence on inadequate health care resources, 
including health care professionals, as a barrier to access[20]. The restrictive 
prescription practices have important implications for the region given critical shortages 
of health workers, especially doctors, the commonest prescribers, with a failure to 
comply with the WHO 2.28/1000 (health worker to population) recommendation[53]. 
This is a serious concern for a region characterized by limited access to trained doctors, 
and an escalating burden of HIV and NCDs[46]. Integral to the concern of human 
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resource shortage is the significant inequitable distribution of health workers in urban 
versus rural areas [39]. The availability of prescribers is skewed towards urban settings 
in situations where currently only doctors are allowed to prescribe opioid analgesics. 
These prescribers are also more likely to be stationed at urban-based secondary or 
higher levels of service delivery. With the majority of the population living in rural areas, 
patients may have to travel long distances to access prescription points.  This problem 
raises a multitude of concerns in terms of equitable access to opioid medicines for pain 
relief.  
 
The conventional doctor-led model in opioid medicine prescription may be justifiable 
because of the complexity involved in their handling and prescription. Nevertheless, 
innovation is urgently needed to address associated challenges faced in African 
settings.  The WHO recommends re-structuring health service models to accommodate 
task shifting as a way of solving acute human resource for health shortages[54]. Task 
shifting involves transferring specific tasks to different cadres of health workers with 
shorter training experience and fewer qualifications. It may also include delegation of 
specified duties to cadres who receive targeted training to acquire a specific set of skills 
[23]. Notably, the definition of the various cadres of non-physician health workers differs 
from country to country[29], making country-specific plans important in rolling out this 
agenda. For example, Hospice Africa Uganda currently provides a course for nurse 
prescribers, preparing them for the prescription role. This corresponds to high-resource 
countries like the USA, where nurse-practitioners can prescribe opioids in many 
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states[1]. Evidence for effectiveness of the task shifting of this role is urgently needed to 
support its role out in the field of opioid medicine prescription in the region.  
 
Globally, there is an enormous, increasing gap between the need for, and availability of, 
opioid analgesics, and this is increasingly skewed against people living in poverty[22]. 
For Southern African countries,  
 
Conclusion 
Numerous barriers to effective pain management have been identified across 
legislation, supply and clinical use of opioids in three Southern African countries. In 
response to barriers identified in this work we present recommendations for future 
initiatives to enhance pain management that are specific to the Southern African 
context. However, these have relevance to palliative care providers across the SSA 
region. Recommendations require adaptation to the local country in which they are 
implemented alongside research activities to explore their effectiveness. 
Recommendations include advocacy for policy changes, revisions to prescribing 
restrictions, exploring the scope for local opioid morphine production, reducing user 
fees, and addressing knowledge gaps at the level of policy, government and health 
professionals. Pursuing these initiatives, influencing all levels of the opioid supply chain, 
aim to improve the management of pain for patients suffering with progressive disease 
and reduce the extensive avoidable suffering reported in this region.  
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Fig. 1: Overview of opioid supply chain levels with identified issues and proposed 
context-specific approaches to aid improvement  
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Table 1: characteristics of these three Sub-Saharan African countries 
Description  Mozambique Swaziland Zimbabwe 
Population (in million) 2015 [1] 27.98 1.27 15.6 
Gross national income (GNI) per capita (US$) 
2012 [3] 
510 2860 680 
Children 0-14 years 2015 [1] 45.3% 37.3 % 41.6 % 
    
Life expectancy at birth (years) 2012 49.9 48.9 56.1 
Annual number of under-5 deaths (thousands) 
2012 [3] 
84 3 39 
Adult HIV prevalence (%) 2012 [3] 11.1 26.5 14.7 
Children living with HIV (thousands) 2012 [3] 180 22 180 
Cancer mortality (2012) [4] 17,017 628 11,423 
    
    
Total amount of morphine equivalent consumed  
in 2012 
4.7kg Not 
reported 
10.1kg 
Morphine needed to meet minimum demand from 
deaths due to HIV or cancer (kg) 
177kg 20kg 322kg 
Deaths with moderate/severe pain 52,114 3,252 28,638 
People dying of HIV or cancer with untreated 
moderate/severe pain: 
51,348 3,252 27,001 
Based on morphine equivalent consumed, 
coverage of deaths in pain with treatment  
1.5% 0.0% 5.7% 
Percentage gap in coverage of deaths in pain with 
analgesics treatment: 
98.5% 100% 94.3% 
Data from (1) http://data.worldbank.org (2015); (2) http://www.painpolicy.wisc.edu/countryprofiles (3) 
https://www.unicef.org/infobycountry/zimbabwe_statistics.html [4] http://globocan.iarc.fr/Pages/summary_table_pop_sel.aspx   
[5] Treat the Pain (2014) 
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Table 2: Documents reviewed for each country and comments on the documents   
Country Policies Regulatory frameworks and other relevant 
documents identified 
Comments on documents  
M
o
z
a
m
b
i
q
u
e
 
• Palliative Care 
National Policy of 
2012:12 
• Criminal Jurisdiction Legal Framework 
Applicable to Trafficking and Consumption 
Narcotic Drugs, Psychotropic Substances, 
Precursors and other substances Similar Effects 
Law No. 3/97, dated 13 September 1997 
 
• African Palliative Care Association (ACPA) 
Standards for Providing Palliative Care in Africa 
(2011). These were (adopted by Mozambique in 
2012) 
 
• Pocket Guide to Pain Management 2nd Edition 
(2012). Adopted from APCA and translated into 
Portuguese. 
 
• National Formulary Medicines  
• There are several documents that refer to palliative 
care and opioids. 
 
• Effects Law No 3/97, dated 13 September 1997, 
which has been superseded by events and does not 
match or meet the current situational needs. This 
law was enacted in 1997 and has not been revised 
to address changes in disease epidemiology; for 
example, escalating incidence and prevalence of 
cancer, HIV and other NCDs for which pain is a 
highly prevalent symptom.  This moderate/severe 
pain is best managed using opioids to reduce 
unnecessary suffering. This law is still in effect in 
Mozambique.  
 
• The National Strategic HIV and AIDS Response Plan 
2010–2014, does not address issues of pain 
management and only briefly mentioned palliative 
care under the home-based care section. 
S
w
a
z
i
l
a
n
d
 
• National Palliative 
Care Policy 
(Ministry of Health, 
2011) 
 
• National 
pharmaceutical 
policy (2011) 
• National Palliative Care Trainees Manual (2013) 
 
• Curriculum for pharmacy certificate program (no 
date) 
 
• Standard Treatment Guideline and Essential 
Medicines List of Common Medical Conditions in 
the Kingdom of Swaziland (2012) 
 
• Swaziland Pharmaceutical Strategic Plan of 
2012-2016 (Ministry of Health, 2012a) 
• Swaziland’s 1929 Pharmacy Act and 1922 Opium 
and Habit Forming Drugs Act were long outdated; 
as they do not provide for licencing and regulatory 
functions.  Two new bills (a Pharmacy Bill of 2012 
and a Medicines Bill of 2012) are yet to be enacted 
into law, for now the existing acts are still in effect.  
 
• Swaziland’s Pharmaceutical Strategic Plan for 
2012–2016, page 17, the opioids are listed as 
essential medicines.  
 
• The Pharmaceutical Policy of 2011 talks about 
control (Article 6.2.2) as well as the supply of all 
essential medicines (Article 6.3). 
 
• The National Palliative Care Guidelines (MoH 
Swaziland, 2011a:15) state that “morphine is the 
most commonly used opioid and is still the absolute 
standard”. 
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Country Policies Regulatory frameworks and other relevant 
documents identified 
Comments on documents  
Z
i
m
b
a
b
w
e
 
• The National 
Medicines Policy 
(2011) 
• Dangerous Drugs Act (Chapter 15:02) of 
Zimbabwe 
 
• The Medicines and Allied Substances Control 
Act (Chapter 15:03) of 1969 
 
• National HIV and AIDS strategic plan (2011) 
• The Dangerous Drugs Act (Chapter 15:02) does not 
accommodate the concept of ‘balance’ to enhance 
availability of opioids for rational medical and 
scientific use of opioids. 
 
• In the National Medicines Policy of Zimbabwe 
(MOHCW, 2011), opioids are classified as vital 
drugs but with ‘B’ availability –, these medicines can 
only be stocked at   hospital level. 
 
• The Medicines and Allied Substances Control Act 
(Chapter 15:03) of 1969 established the Medicines 
Control Authority of Zimbabwe (MCAZ), which 
controls the manufacturing, import/export and 
distribution of medicines, including opioids.  
 
• As per the National Health Strategy of Zimbabwe 
2009–2013 page 9), access to all essential drugs 
was not good, ranging between “29% and 58% for 
vital items-including opioids, and 22% to 36% for all 
items”.  
 
• There is a national HIV and AIDS Strategic Plan for 
2011–2015 (National AIDS Council of Zimbabwe, 
2011), which states that palliative care is one of the 
services to be provided under community-based 
health care (CBHC), with a goal to scale it up to 
85% by 2015. 
 
• As per the National Medicines Policy (Ministry of 
Health and Child Welfare, 2011) government is 
obliged to provide ‘vital’ medicines including opioids.  
 
• The  national HIV and AIDS Strategic Plan for 
2011–2015 (National AIDS Council of Zimbabwe, 
2011), states that palliative care is one of the 
services to be provided under community-based 
health care (CBHC), with a goal to scale it up to 
85% by 2015. 
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Table 3: Participants recruited to the study (n=121) 
Group Interview participants (n=33) 
Country  Informant category  
 National AIDS 
Program/ 
palliative care 
association 
Government 
Policy  
Personnel 
Government 
Licensing  
Personnel 
Government 
Supply chain 
personnel 
Service 
Providers 
Law 
enforcement  
Personnel 
Total 
number    
Mozambique 4 4 1 1 1 0 11 
Swaziland 4 2 1 0 4 0 11 
Zimbabwe 1 2 1 1 5 1 11 
Total 9 8 3 2 10 1 33 
key informant questionnaire (n=88) 
Country  Informant category 
 National AIDS 
Program/ 
palliative care 
association 
Government 
Policy  
Personnel 
Government 
Licensing  
Personnel 
Government 
Supply chain 
technocrats 
Service 
Providers 
Law 
enforcement  
Personnel 
Total 
number    
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Mozambique 2 3 1 0 20 0 26 
Swaziland 3 8 5 0 9 5 30 
Zimbabwe 7 1 1 2 16 5 32 
Total 12 12 7 2 45 10 88 
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Table 4: Gaps in Controlled medicines practices around estimation, prescription and dispensing 
in patient care  
Mozambique  Swaziland  Zimbabwe  
Supply related challenges   at national level  
• Estimation is based 
previous year’s 
consumption alone a 
method likely to under 
estimate actual need. +  
 
• Stock outs were common 
and largely attributed to 
the bureaucratic 
tendering process.   
 
• Morphine is imported 
using foreign currency 
which is scarce, 
compromising 
importation and 
distribution.  
 
• Estimation is based 
previous year’s 
consumption alone a 
method likely to under 
estimate actual need. +  
 
• Irregularities mentioned 
in submitting reports to 
the International 
Narcotics board, yet Non-
compliance to reporting 
can compromise supply.  
 
• Human resource shortage 
concerns were commonly 
mentioned and linked to 
irregularities in 
submitting INCB reports 
• Estimation is based 
previous year’s consumption 
alone a method likely to 
under estimate actual need. 
+ 
 
 
Barriers at service delivery level   
Mozambique  Swaziland  Zimbabwe  
• Proximate to services 
access centers as morphine 
is not available at primary 
health care level which is 
closer to the communities’ 
residential areas.  
 
• Restrictive prescription 
regulations (only doctors 
are allowed to prescribe)  
• lack of critical mass for 
prescribers  
•  User fees is a barrier to 
access for the poor   
 
• Proximity to services; 
rural vs urban imbalance 
in service access points.  
• Restrictive prescription 
regulations (only doctors 
are allowed to prescribe) 
• Lack of critical mass for 
prescribers  
• User fee of $1  is a 
barrier at the point of 
access  
 
 
• Proximity to services, there 
are long distances to service 
delivery centres as morphine 
is not stocked at primary 
health care level.  
 
• There is a rural vs urban 
imbalance as prescribers and 
services centres are largely 
urban based in service 
access points 
 
• Frequent stock outs of 
opiods 
 
• User fee at the point of 
service access is a barrier  
+ Morbidity data and the population size are not used in estimating need 
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Table 5: Characteristics of questionnaire respondents (n=88) 
 
Country Total 
Characteristic Mozambique (n=26) 
Swaziland 
(n=30) 
Zimbabwe 
(n=32) n = 88 
Sex Male 9 (36%) 15 (50% 8 (25%) 32 (36.4%) Female 17 (64%) 15 (50%) 24 (75%) 56 (63.6%) 
Age category 
(years) 
≤ 30 8 (16%) 5 (16%) 3 (9%) 16 (18.2%) 
31 – 40 5 (19%) 12 (40%) 8 (25%) 25 (28.4%) 
41 – 50 9 (35%) 8 (27%) 13 (41%) 30 (34.1%) 
≥51 4 (15%) 5 (17) 8 (25%) 17 (19.3%) 
Profession  
Physician 1 (4%) 5 (16%) 3 (9%) 9 (10.2%) 
Nurse 14 (54%) 14 (47%) 17 (53%) 45 (51.1%) 
Pharmacist 7 (27%) 2 (7%) 7 (22%) 16 (18.2%) 
Non-medical 4 (15%) 9 (30%) 5 (15.6%) 18 (20.4%) 
Last time in pain 
management 
training 
<1yr 7 (27%) 13 (43%) 14 (44%) 34 (39%) 
1-5 yrs. 10 (39%) 9 (30%) 9 (28%) 28 (32%) 
>5yrs 9 (34%) 5 (17%) 4 (13%) 18 (20%) 
Do not know 0 3 (10%) 5 (15%) 8 (9%) 
Role in opioids 
availability 
Policy formulation 3 (11%) 8 (27%) 1 (3%) 12 (13.2%) 
With palliative care 
program 2(8%) 3 (10%) 7 (22%) 12 (13.2%) 
Licensing Authority 1(4%) 1 (3%) 1 (3%) 3 (3.4%) 
Service provider 20 (77%) 9 (30%) 16 (50%) 45 (51.1%) 
Law enforcement 0 5 (17%) 5 (16%) 10 (11.4%) 
Other 0 4 (13%) 2 (6%) 6 (6.8%) 
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Table 6: Knowledge attitudes and practices regarding opioid analgesic supply, distribution and storage  
  Doctors and 
pharmacists 
(n=25) 
Nurses 
 (n=45) 
Non-medical 
(n=18) 
 Awareness on national collaboration with INCB requirements 
1 My country is signatory to the international drug control 
conventions. 15(60.0%) 24(53.3%) 11(61.1%) 
2 Government is required to submit quarterly and annual 
statistical reports on import and exports. 21(84.0%) 31(68.9%) 13(72.2%) 
3 The WHO has model drug lists of essential medicines 
which includes opioid analgesics. 22(88.0%) 36(80.0%) 13(72.2%) 
4 It is the Government’s obligation, in collaboration with 
the International Narcotics Control Board (INCB), to 
ensure that opioid analgesics are adequately available. 
24(96.0%) 35(77.8%) 12(66.7%) 
5 INCB recommends that member countries develop a 
tailored practical method, through national competent 
authorities, to select, quantify, procure, store, distribute 
and use controlled medicines including opioid 
analgesics. 
22(88.0%) 31(68.9%) 14(77.8%) 
6 In a case of underestimation of controlled medicines, 
the Government has the option of submitting 
supplementary estimates to the INCB. 
20(80.0%) 31(68.9%) 13(72.2%) 
 Awareness of governments’ responsibility to integrate opioids in relevant national pharmaceutical and disease 
specific policies 
7 Government should include the availability and 
accessibility of controlled medicines, including opioids, 
for all relevant medical uses in their national 
pharmaceutical policy plans. 
22 (88%) 40 (88.9%) 14 (77.8%) 
8 Access to, and availability of, strong opioid analgesics 
should be included in specific national disease control 
programs, such as that of HIV and AIDS and cancer  
20 (80%) 38 (84.4%) 15 (83.3%) 
9 Similar to any other medicine, controlled medicines 
need to be in stock in order for it to be continuously 23 (92%) 41 (91.1%) 13 (72.2%) 
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  Doctors and 
pharmacists 
(n=25) 
Nurses 
 (n=45) 
Non-medical 
(n=18) 
available for prescription when needed. 
 Knowledge on regulating the distribution, storage and prescription of opioids 
10 To avoid illicit use, controlled substances availability 
should only be limited to hospital or large pharmacies 
with stringent safety measures. ** 
5 (20.0%) 15 (33.3%) 2 (11.1%) 
11 Very stringent safety measures regarding storage of 
opioids are required to: ensure prevention of diversion, 
improve availability and affordability of controlled 
medicines. ** 
1 (4.0%) 1(4.0%) 5 (28.8%) 
12 The INCB recommends that for a pharmacy to be 
allowed to stock controlled medicines, such as opioid 
analgesics, they must first invest in additional safety 
measures to ensure safety of the medicines. 
3 (12.0%) 2 (4.4%) 1 (5.5%) 
13 There is need to review control and safety measures 
and the impact on controlled medicines pricing 19 (76.0%) 41 (91.1%) 15 (83.3%) 
14 End stage AIDS patients may suffer from pain which 
may require use of strong opioids analgesics for pain 
control. 
22 (88.0%) 38 (84.4%) 16 (88.9%) 
15 Physicians, nurses and other health professionals who 
are trained and qualified, at all levels of health care 
should be allowed to prescribe. 
10 (40.0%) 29 (64.4%) 6 (33.3%) 
16 Medical prescription of opioids for pain control should 
only be for a limited time. ** 11 (44.0%) 28 (62.2%) 7 (38.9%) 
17 To be eligible to receive opioids analgesics, patients 
must be specifically registered and authorized. 5 (20%) 15 (33.3%) 2 (11.1%) 
 Attitudes of participants regarding opioid consumption estimates, importation, storage, distribution and prescription 
18 To prevent diversion and illicit use, only government 
should estimate, import, store and distribute opioid 
analgesics. ** 
9 (36.0%) 16 (35.5%) 4 (22.2%) 
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  Doctors and 
pharmacists 
(n=25) 
Nurses 
 (n=45) 
Non-medical 
(n=18) 
19 Government’s main obligation is to ensure that 
controlled medicines, such as opioid analgesics, are 
not diverted for illicit use. 
8 (32.0%) 5 (11.1%) 0 (0%) 
20 Stores or pharmacies to be certified for storage of 
opioids must, in addition to usual requirements, must 
have additional specific security. 
2 (8.0%) 4 (8.9%) 0 (0%) 
21 To ensure prevention of abuse and illicit use, the 
distribution of controlled medicines including opioids 
should not be combined with that of other non-
controlled medicines distribution systems. ** 
6 (24.0%) 9 (20.0%) 1 (5.6%) 
22 Only pharmacies and hospitals should be permitted to 
dispense controlled medicines. ** 12 (48.0%) 14 (31.1%) 5 (27.8%) 
23 Only medical doctors and pharmacists should be 
allowed to prescribe opioid analgesics. ** 11 (44.0%) 22 (48.9%) 13 (72.2%) 
 
Key: In italics = scores <70% (indicating an undesirable score); % = proportion of responses with agree/strongly agree; items with 
** = % proportion of responses with disagree/strongly disagree  
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Head of the Inspection Unit in the PD
Central Medical Store (CMS)
INCB
 Frequent occurrence of stockouts of 
opioids resulting from the tendering 
process requirements and scarcity of 
resources (particulary US dollars required 
for the importation of the opioids)
Pharmaceutical Department (PD)
 Current estimation procedures are irregular 
(often completed annually) and rely on 
consumption data from previous years 
 Ratio of doctors within broader healthcare 
workforce is very low (e.g. in Mozambique 
there are 34,500 health workers and 3.2% 
are doctors)
 Prescriber reluctant to prescribe due to 
fear of making mistakes, fear of patient 
addiction and the additional paper work 
required
 Doctors, the legal prescribers, were mostly 
urban based and yet most of the 
population was rural based
Healthcare workforce
Service users and caregivers
 User fees exist at  at the point of access 
(e.g. $0.17 in Mozambique) 
 Average distance moved by service users is 
about 10 kilometers
Levels of opioid supply 
chain Barriers identified Proposed solutions
 Provision of training and support to ensure 
adequate opioid reporting is achieved at the 
Pharmaceutical Department and Head of the 
Inspection Unit levels of the supply chain
 Hold Southern Africa regional training seminar for 
national authorities responsible for the 
implementation of the international drug control 
conventions, including training on estimates.  
 Incomplete and erroneous reporting 
received
 Improve access to opioids up to the primary 
healthcare level by streamlining the supply chain 
to integrate morphine into the essential 
medicines list and standard treatment guidelines
 Opt for low cost formulations 
 Provide pharmaceutical opioids management and 
logistics training to staff in the PD Inspection Unit 
and the CMS
 Facilitate dialogue with PD around reporting on 
disease burden and opioid prescribing
 High occurrence of opioid stock outs 
reported to medicines regulatory authority
 Lack of financial resources to import opioid 
analgesics
 Limited data available on burden of disease 
and opioid prescribing 
 Train key staff in estimation procedures
 Strengthen use of data to understand disease 
burden, which can complement consumption 
data in opioid needs estimation
 Improve access and availability of morphine by 
providing technical assistance and support 
towards local manufacturing mirroring initiatives 
already done in Uganda at Hospice Africa Uganda
 Staff could engage with continued medical 
education (CME), such as pain management at 
the clinical level. 
 Provision of training and education from 
ministries of health to target identified barriers to 
opioid prescribing at the healthcare professional 
level
 Ministries of health should evaluate the 
composition of their healthcare workforce to 
identify how greater levels of prescribing can be 
achieved (e.g. increase doctor numbers, 
authorise additional health professional roles to 
prescribe)
 Ministries of Health should explore ways of 
reducing or overcoming the urban imbalance of 
doctors 
 Exemption from fees for the very poor and 
patients with chronic diseases such as HIV, 
cancers and TB
 Explore innovative approaches to accessing 
patients to reduce need for travel (e.g. mobile 
teams from hospice sites, establishing satellite 
clinics, use of mobile health technology)
